Vnitr Lek 2022, 68(3):E12-E17 | DOI: 10.36290/vnl.2022.041

Acute infections in kidney transplant recipients

Zdeněk Lys1, 3, Klára Dombrovská1, Jarmila Dědochová1, Petra Kovářová2, Ivo Valkovský1, 3, Jan Václavík1, 3
1 Interní a kardiologická klinika, FN Ostrava
2 Krevní centrum, FN Ostrava
3 Lékařská fakulta, Ostravská univerzita

Immunosuppressed kidney transplant recipients have a high risk of infectious complications. A variety of infections of viral, bacterial, or mycotic etiology, including opportunistic infections, occur in this group of patients, but bacterial infections are primarily responsible for the high infection-related mortality. Of the bacterial infections, urinary tract infections and pneumonia are the most common, often requiring hospitalization and temporary reduction of immunosuppressive therapy after consultation of the transplant center. In addition to symptoms due to the location of the infection, fever is often present. The differential diagnosis of fever and/or high inflammatory activity is specific to patients after kidney transplantation. In addition to infectious causes, we consider drug-related fever, a rejection episode, a relapse of systemic disease or in patients with graft failure in dialysis treatment graft intolerance syndrome ("symptomatic graft"). Saving the patient's life, which often requires a significant reduction in immunosuppressive therapy, always takes precedence over preventing a rejection episode. Infection prevention is an integral part of the care of transplant patients, including the recommendation of vaccination where possible.

Keywords: acute infection, antibiotics, immunosuppression, kidney transplantation, rejection.

Published: April 26, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lys Z, Dombrovská K, Dědochová J, Kovářová P, Valkovský I, Václavík J. Acute infections in kidney transplant recipients. Vnitr Lek. 2022;68(3):E12-17. doi: 10.36290/vnl.2022.041.
Download citation

References

  1. Obert R, Olfe AW, Alarie V et al. Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant. http://dx.doi.org/101056/NEJM199912023412303 [Internet]. 2008 Oct 21 [cited 2021 Dec 12];341(23):1725-30. Available from: https://www.nejm.org/doi/full/10.1056/nejm199912023412303 Go to original source... Go to PubMed...
  2. Kostro JZ, Hellmann A, Kobiela J et al. Quality of Life After Kidney Transplantation: A Prospective Study. Transplant Proc. 2016 Jan 1;48(1):50-4. Go to original source... Go to PubMed...
  3. Statistiky | Koordinační středisko transplantací (KST) [Internet]. [cited 2021 Dec 12]. Available from: https://kst.cz/statistiky/
  4. Wohlfahrtová M, Ondřej Viklický LR. Transplantace orgánů v klinické praxi. 1. Praha: Grada Publishing, a. s.; 2021. 416 p. ISBN 978-80-271-0721-6.
  5. Jackson KR, Motter JD, Bae S et al. Characterizing the landscape and impact of infections following kidney transplantation. Am J Transplant. 2021 Jan 1;21(1):198-207. Go to original source... Go to PubMed...
  6. Awan AA, Niu J, Pan JS et al. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014) Keywords Kidney transplant . Cause‑specific death . Cardiovascular disease . Malignancy. Am J Nephrol [Internet]. 2018 [cited 2021 Dec 12];48:472-81. Available from: www.karger.com/ajn Go to original source... Go to PubMed...
  7. Ying T, Shi B, Kelly PJ et al. Death after kidney transplantation: An analysis by era and time post‑transplant. J Am Soc Nephrol [Internet]. 2020 Dec 1 [cited 2021 Dec 12];31(12):2887-99. Available from: https://jasn.asnjournals.org/content/31/12/2887 Go to original source... Go to PubMed...
  8. Au EH, Chapman JR, Craig JC et al. Overall and site‑specific cancer mortality in patients on dialysis and after kidney transplant. J Am Soc Nephrol [Internet]. 2019 Mar 1 [cited 2021 Dec 12];30(3):471-80. Available from: https://jasn.asnjournals.org/content/30/3/471 Go to original source... Go to PubMed...
  9. Kinnunen S, Karhapää P, Juutilainen A et al. Secular trends in infection‑related mortality after kidney transplantation. Clin J Am Soc Nephrol [Internet]. 2018 May 7 [cited 2021 Dec 12];13(5):755-62. Available from: https://cjasn.asnjournals.org/content/13/5/755 Go to original source... Go to PubMed...
  10. Fishman JA, Fishman JA. Infection in Organ Transplantation. Am J Transplant. 2017;17(4):856-879. doi:10.1111/AJT.14208 Go to original source... Go to PubMed...
  11. Kalil AC, Opal SM. Sepsis in the Severely Immunocompromised Patient. CurrInfect Dis Rep 17, 32 (2015). Available from: https://doi.org/10.1007/s11908-015-0487-4 Go to original source... Go to PubMed...
  12. Lubetzky M, Tantisattamo E, Molnar MZ et al. The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients. Vol. 21, American Journal of Transplantation. John Wiley and Sons Inc; 2021. p. 2937-49. Go to original source... Go to PubMed...
  13. Sawyer RG, Crabtree TD, Gleason TG et al. Impact of solid organ transplantation and immunosuppression on fever, leukocytosis, and physiologic response during bacterial and fungal infections. Clin Transplant [Internet]. 1999 Mar 1 [cited 2021 Dec 12];13(3):260-5. Available from: https://onlinelibrary.wiley.com/doi/full/10.1034/j.1399-0012.1999.130307.x Go to original source... Go to PubMed...
  14. Chertow GM, Burdick E, Honour M et al. Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients. J Am Soc Nephrol [Internet]. 2005 Nov 1 [cited 2021 Dec 13];16(11):3365-70. Available from: https://jasn.asnjournals.org/content/16/11/3365 Go to original source... Go to PubMed...
  15. Peeters P, Laecke S Van, Vanholder R. ACUTE KIDNEY INJURY IN SOLID ORGAN TRANSPLANT RECIPIENTS. http://dx.doi.org/101179/acb2007087 [Internet]. 2014 Jan [cited 2021 Dec 13];62(sup2):389-92. Available from: https://www.tandfonline.com/doi/abs/10.1179/acb.2007.087 Go to original source... Go to PubMed...
  16. Moledina DG, Perazella MA. Drug‑Induced Acute Interstitial Nephritis. Clin J Am Soc Nephrol [Internet]. 2017 Dec 7 [cited 2021 Dec 13];12(12):2046. Available from: /pmc/articles/PMC5718279/ Go to original source... Go to PubMed...
  17. Bafi AT, Tomotani DYV, De Freitas FGR. Sepsis in solid‑organ transplant patients. Shock [Internet]. 2017 [cited 2021 Dec 12];47:12-6. Available from: https://journals.lww.com/shockjournal/Fulltext/2017/01001/Sepsis_in_Solid_Organ_Transplant_Patients.4.aspx Go to original source... Go to PubMed...
  18. Gupta RK. Opportunistic Infections in Renal Allograft Recipients. Transplant Proc. 2007 Apr 1;39(3):731-3. Go to original source... Go to PubMed...
  19. Santos T, Aguiar B, Santos L et al. Invasive Fungal Infections After Kidney Transplantation: A Single‑center Experience. Transplant Proc. 2015 May 1;47(4):971-5. Go to original source... Go to PubMed...
  20. Infante B, Rossini M, Leo S et al. Molecular Sciences Recurrent Glomerulonephritis after Renal Transplantation: The Clinical Problem. [cited 2021 Dec 13]; Available from: www.mdpi.com/journal/ijms
  21. Al‑Adra D, Al‑Qaoud T, Fowler K et al. De Novo Malignancies after Kidney Transplantation. Clin J Am Soc Nephrol [Internet]. 2021 Mar 29 [cited 2021 Dec 13];17:CJN.14570920. Available from: https://cjasn.asnjournals.org/content/early/2021/02/17/CJN.14570920
  22. Terasaki PI, Ozawa M. Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial. Am J Transplant [Internet]. 2004 Mar 1 [cited 2021 Dec 12];4(3):438-43. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1600-6143.2004.00360.x Go to original source... Go to PubMed...
  23. Yahav D, Sulimani O, Green H et al. Immunosuppression reduction in kidney transplant recipients during bacterial infection-A retrospective study. Clin Transplant [Internet]. 2019 Oct 1 [cited 2021 Dec 6];33(10):e13707. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/ctr.13707 Go to original source... Go to PubMed...
  24. Säemann M, Hörl WH. Urinary tract infection in renal transplant recipients. Eur J Clin Invest [Internet]. 2008 Oct [cited 2021 Dec 6];38(SUPPL.2):58-65. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2362.2008.02014.x Go to original source... Go to PubMed...
  25. Singh R, Geerlings SE, Peters‑Sengers H et al. Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft function. Transpl Infect Dis [Internet]. 2016 Oct 1 [cited 2021 Dec 6];18(5):647-60. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/tid.12568 Go to original source... Go to PubMed...
  26. Maanaoui M, Baes D, Hamroun A et al. Association between acute graft pyelonephritis and kidney graft survival: A single‑center observational study. Am J Transplant [Internet]. 2021 Nov 1 [cited 2021 Dec 6];21(11):3640-8. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/ajt.16703 Go to original source... Go to PubMed...
  27. Korth J, Kukalla J, Rath P‑M et al. Increased resistance of gram‑negative urinary pathogens after kidney transplantation. BMC Nephrol 18, 164 (2017). https://doi.org/10.1186/s12882-017-0580-z Go to original source... Go to PubMed...
  28. Lee JR, Bang H, Dadhania D et al. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: A single‑center report of 1166 kidney allograft recipients. Transplantation [Internet]. 2013 Oct 27 [cited 2021 Dec 6];96(8):732-8. Available from: https://journals.lww.com/transplantjournal/Fulltext/2013/10270/Independent_Risk_Factors_for_Urinary_Tract.9.aspx
  29. Kara S, Sen N, Kursun E et al. Pneumonia in renal transplant recipients: A single‑center study. Exp Clin Transplant. 2018 Mar 1;16:122-5.
  30. Guidelines | Pneumologie [Internet]. [cited 2021 Dec 14]. Available from: http://www.pneumologie.cz/guidelines/?potvrzeni1=1 & potvrzeni2=1 & potvrdit=ANO%0D%0 A%0D%0A++++Vstoupit#
  31. Transplant Recipient - KDIGO [Internet]. [cited 2021 Dec 13]. Available from: https://kdigo.org/guidelines/transplant‑recipient/




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.